148 related articles for article (PubMed ID: 8852521)
1. Drugs during pregnancy: an issue of risk classification and information to prescribers.
Sannerstedt R; Lundborg P; Danielsson BR; Kihlström I; Alván G; Prame B; Ridley E
Drug Saf; 1996 Feb; 14(2):69-77. PubMed ID: 8852521
[TBL] [Abstract][Full Text] [Related]
2. Drug use during pregnancy and breast-feeding. A classification system for drug information.
Berglund F; Flodh H; Lundborg P; Prame B; Sannerstedt R
Acta Obstet Gynecol Scand Suppl; 1984; 126():1-55. PubMed ID: 6393685
[TBL] [Abstract][Full Text] [Related]
3. Risk classification systems for drug use during pregnancy: are they a reliable source of information?
Addis A; Sharabi S; Bonati M
Drug Saf; 2000 Sep; 23(3):245-53. PubMed ID: 11005706
[TBL] [Abstract][Full Text] [Related]
4. Prescription of hazardous drugs during pregnancy.
Malm H; Martikainen J; Klaukka T; Neuvonen PJ
Drug Saf; 2004; 27(12):899-908. PubMed ID: 15366977
[TBL] [Abstract][Full Text] [Related]
5. Risk management strategies in the Physicians' Desk Reference product labels for pregnancy category X drugs.
Uhl K; Kennedy DL; Kweder SL
Drug Saf; 2002; 25(12):885-92. PubMed ID: 12241129
[TBL] [Abstract][Full Text] [Related]
6. Evolving knowledge of the teratogenicity of medications in human pregnancy.
Adam MP; Polifka JE; Friedman JM
Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):175-82. PubMed ID: 21766440
[TBL] [Abstract][Full Text] [Related]
7. Teratogenicity of recently introduced medications in human pregnancy.
Lo WY; Friedman JM
Obstet Gynecol; 2002 Sep; 100(3):465-73. PubMed ID: 12220765
[TBL] [Abstract][Full Text] [Related]
8. The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule.
Brucker MC; King TL
J Midwifery Womens Health; 2017 May; 62(3):308-316. PubMed ID: 28556499
[TBL] [Abstract][Full Text] [Related]
9. Potential human teratogenicity of frequently prescribed drugs.
Friedman JM; Little BB; Brent RL; Cordero JF; Hanson JW; Shepard TH
Obstet Gynecol; 1990 Apr; 75(4):594-9. PubMed ID: 2314777
[TBL] [Abstract][Full Text] [Related]
10. Report of the Teratology Society Public Affairs Committee symposium on FDA classification of drugs.
Friedman JM
Teratology; 1993 Jul; 48(1):5-6. PubMed ID: 8102499
[No Abstract] [Full Text] [Related]
11. Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population.
Yang T; Walker MC; Krewski D; Yang Q; Nimrod C; Garner P; Fraser W; Olatunbosun O; Wen SW
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):270-7. PubMed ID: 18181228
[TBL] [Abstract][Full Text] [Related]
12. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents).
Brent RL
Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191
[TBL] [Abstract][Full Text] [Related]
13. FDA classification of drugs for teratogenic risk. Teratology Society Public Affairs Committee.
Teratology; 1994 Jun; 49(6):446-7. PubMed ID: 7747265
[TBL] [Abstract][Full Text] [Related]
14. Dispensing of potentially teratogenic drugs before conception and during pregnancy: a population-based study.
Zomerdijk IM; Ruiter R; Houweling LM; Herings RM; Straus SM; Stricker BH
BJOG; 2015 Jul; 122(8):1119-29. PubMed ID: 25316196
[TBL] [Abstract][Full Text] [Related]
15. Teratogen update: evaluation of the reproductive and developmental risks of caffeine.
Christian MS; Brent RL
Teratology; 2001 Jul; 64(1):51-78. PubMed ID: 11410911
[TBL] [Abstract][Full Text] [Related]
16. Association between change of health care providers and pregnancy exposure to FDA category C, D and X drugs.
Yang J; Xie R; Krewski D; Wang Y; Walker M; Cao W; Wen SW
Chin Med J (Engl); 2014; 127(4):702-6. PubMed ID: 24534226
[TBL] [Abstract][Full Text] [Related]
17. Prescription drug use in pregnancy.
Andrade SE; Gurwitz JH; Davis RL; Chan KA; Finkelstein JA; Fortman K; McPhillips H; Raebel MA; Roblin D; Smith DH; Yood MU; Morse AN; Platt R
Am J Obstet Gynecol; 2004 Aug; 191(2):398-407. PubMed ID: 15343213
[TBL] [Abstract][Full Text] [Related]
18. Use of prescription medications with a potential for fetal harm among pregnant women.
Andrade SE; Raebel MA; Morse AN; Davis RL; Chan KA; Finkelstein JA; Fortman KK; McPhillips H; Roblin D; Smith DH; Yood MU; Platt R; H Gurwitz J
Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):546-54. PubMed ID: 16586470
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of prescribing in pregnancy using the Irish primary care research network: a pilot study.
Dillon P; O'Brien KK; McDonnell R; Donnelly-Swift E; Galvin R; Roche A; Cronin K; Walsh DR; Schelten R; Smith S; Fahey T
BMC Pregnancy Childbirth; 2015 Mar; 15():67. PubMed ID: 25884886
[TBL] [Abstract][Full Text] [Related]
20. Categorizing the safety of medications during pregnancy and lactation.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2009 Apr; 47(4):17-20. PubMed ID: 19437927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
